Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

41.18 +0.24 (+0.59%)
Delayed Quote Updated: 10:46 AM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 102,561
Open 41.21
Bid (Size) 41.19 (200)
Ask (Size) 41.23 (100)
Prev. Close 40.94
Today's Range 40.02 - 41.30
52wk Range 28.95 - 49.32
Shares Outstanding 46,631,158
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
From Wall Street Investor
Via GlobeNewswire

Performance

52-Week Range 16.5% below 52-week high
41.18
28.9552W Low 49.3252W High
1 Week 1.0% below 1-week high
39.711W Low 41.601W High

Vericel Corporation - Common Stock (VCEL) traded between $28.95 and $49.32 over the past 52 weeks and last traded at $41.18, 16.5% below its 52-week high. Over the past week it ranged between $39.71 and $41.60.

Past 12 Months
+0.4%
+4.1%
-7.6%
+19.8%
+15.6%
+13.0%
1W +$0.16
1M +$1.63
3M -$3.38
6M +$6.81
YTD +$5.57
1Y +$4.73

VCEL was +13.0% over the past year, +19.8% over six months, +15.6% year to date, +0.4% in the last week.

12 Months vs Market
VCEL
+13.0%
DIA
+11.9%
SPY
+13.6%
QQQ
+15.8%
IWM
+11.5%

Over the past 12 months VCEL returned +13.0% versus DIA (Dow) +11.9%, SPY (S&P 500) +13.6%, QQQ (Nasdaq 100) +15.8% and IWM (Russell 2000) +11.5%.

Volume & Liquidity 0.20× 3-mo avg
Today 102,561 3-mo avg 508.4K
1W
516.0K
1M
520.0K
3M
508.4K
6M
576.0K
YTD
577.3K
1Y
584.8K

VCEL most recently traded 102,561 shares against a 3-month average daily volume of 508.4K.

More News

Read More
News headline image
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
From Vericel Corporation
Via GlobeNewswire
Vericel (NASDAQ:VCEL) Stands Out on the Affordable Growth Screen ↗
Via Chartmill
Vericel (NASDAQ:VCEL): A Strong Growth Play With an Improving Technical Setup ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL): Growth at a Reasonable Price ↗
Via Chartmill
Vericel (NASDAQ:VCEL) Beats Q2 Estimates, Raises Guidance, Shares Rise ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL): Strong Growth Stock With a Bull Flag Breakout Setup ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL): An Affordable Growth Stock at a Reasonable Valuation ↗
Via Chartmill
News headline image
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
From Biotech Insider
Via GlobeNewswire
News headline image
3 Major Earnings Winners You May Have Missed ↗
Via MarketBeat
Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout ↗
Via Chartmill
Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen ↗
Via Chartmill
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth ↗
Via Chartmill
News headline image
Vericel Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
From World Street Intelligence
Via GlobeNewswire
News headline image
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
MediWound (MDWD) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
From Energy Metal News
Via GlobeNewswire

Frequently Asked Questions

Is Vericel Corporation - Common Stock publicly traded?
Yes, Vericel Corporation - Common Stock is publicly traded.
What exchange does Vericel Corporation - Common Stock trade on?
Vericel Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vericel Corporation - Common Stock?
The ticker symbol for Vericel Corporation - Common Stock is VCEL on the Nasdaq Stock Market
What is the current price of Vericel Corporation - Common Stock?
The current price of Vericel Corporation - Common Stock is 41.18
When was Vericel Corporation - Common Stock last traded?
The last trade of Vericel Corporation - Common Stock was at 10/22/26 10:46 AM ET
What is the market capitalization of Vericel Corporation - Common Stock?
The market capitalization of Vericel Corporation - Common Stock is 1.92B
How many shares of Vericel Corporation - Common Stock are outstanding?
Vericel Corporation - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.